Literature DB >> 24948366

Ectopic lymphoid-like structures in infection, cancer and autoimmunity.

Costantino Pitzalis1, Gareth W Jones2, Michele Bombardieri1, Simon A Jones2.   

Abstract

Ectopic lymphoid-like structures often develop at sites of inflammation where they influence the course of infection, autoimmune disease, cancer and transplant rejection. These lymphoid aggregates range from tight clusters of B cells and T cells to highly organized structures that comprise functional germinal centres. Although the mechanisms governing ectopic lymphoid neogenesis in human pathology remain poorly defined, the presence of ectopic lymphoid-like structures within inflamed tissues has been linked to both protective and deleterious outcomes in patients. In this Review, we discuss investigations in both experimental model systems and patient cohorts to provide a perspective on the formation and functions of ectopic lymphoid-like structures in human pathology, with particular reference to the clinical implications and the potential for therapeutic targeting.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24948366     DOI: 10.1038/nri3700

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  188 in total

1.  Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile.

Authors:  L Le Texier; P Thebault; A Lavault; C Usal; E Merieau; T Quillard; B Charreau; J P Soulillou; M C Cuturi; S Brouard; E Chiffoleau
Journal:  Am J Transplant       Date:  2010-11-29       Impact factor: 8.086

2.  Lineage relationship analysis of RORgammat+ innate lymphoid cells.

Authors:  Shinichiro Sawa; Marie Cherrier; Matthias Lochner; Naoko Satoh-Takayama; Hans Jörg Fehling; Francina Langa; James P Di Santo; Gérard Eberl
Journal:  Science       Date:  2010-09-23       Impact factor: 47.728

3.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

4.  Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure.

Authors:  Youjin Lee; Robert K Chin; Peter Christiansen; Yonglian Sun; Alexei V Tumanov; Jing Wang; Alexander V Chervonsky; Yang-Xin Fu
Journal:  Immunity       Date:  2006-08-24       Impact factor: 31.745

5.  Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane).

Authors:  Dina C Nacionales; Kindra M Kelly; Pui Y Lee; Haoyang Zhuang; Yi Li; Jason S Weinstein; Eric Sobel; Yoshiki Kuroda; Jun Akaogi; Minoru Satoh; Westley H Reeves
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis.

Authors:  S A Luther; T Lopez; W Bai; D Hanahan; J G Cyster
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

Review 7.  Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.

Authors:  Antonio Manzo; Michele Bombardieri; Frances Humby; Costantino Pitzalis
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

8.  Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia.

Authors:  Damiana Chiavolini; Javier Rangel-Moreno; Gretchen Berg; Kate Christian; Laura Oliveira-Nascimento; Susan Weir; Joseph Alroy; Troy D Randall; Lee M Wetzler
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

9.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.

Authors:  Roza I Nurieva; Yeonseok Chung; Daehee Hwang; Xuexian O Yang; Hong Soon Kang; Li Ma; Yi-hong Wang; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong
Journal:  Immunity       Date:  2008-07-03       Impact factor: 31.745

10.  IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).

Authors:  Joanne L Jones; Chia-Ling Phuah; Amanda L Cox; Sara A Thompson; Maria Ban; Jacqueline Shawcross; Amie Walton; Stephen J Sawcer; Alastair Compston; Alasdair J Coles
Journal:  J Clin Invest       Date:  2009-06-22       Impact factor: 14.808

View more
  237 in total

1.  Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.

Authors:  Alexander M S Barron; Julio C Mantero; Jonathan D Ho; Banafsheh Nazari; Katharine L Horback; Jag Bhawan; Robert Lafyatis; Christina Lam; Jeffrey L Browning
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

2.  IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs.

Authors:  Francesca Barone; Saba Nayar; Joana Campos; Thomas Cloake; David R Withers; Kai-Michael Toellner; Yang Zhang; Lynette Fouser; Benjamin Fisher; Simon Bowman; Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Troy D Randall; Davide Lucchesi; Michele Bombardieri; Costantino Pitzalis; Sanjiv A Luther; Christopher D Buckley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

3.  Tertiary Lymphoid Tissue Forms in Retinas of Mice with Spontaneous Autoimmune Uveitis and Has Consequences on Visual Function.

Authors:  Jennifer L Kielczewski; Reiko Horai; Yingyos Jittayasothorn; Chi-Chao Chan; Rachel R Caspi
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

Review 4.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

5.  Characterization of ectopic lymphoid structures in different types of acute renal allograft rejection.

Authors:  K de Leur; M C Clahsen-van Groningen; T P P van den Bosch; G N de Graav; D A Hesselink; J N Samsom; C C Baan; K Boer
Journal:  Clin Exp Immunol       Date:  2018-02-02       Impact factor: 4.330

6.  CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis.

Authors:  Huan He; Jianxiong Wu; Mengya Zang; Weihu Wang; Xiuli Chang; Xiangmei Chen; Ruijun Wang; Zhiyuan Wu; Liming Wang; Dongmei Wang; Fengmin Lu; Zongtang Sun; Chunfeng Qu
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

7.  Intratumoral accumulation of podoplanin-expressing lymph node stromal cells promote tumor growth through elimination of CD4+ tumor-infiltrating lymphocytes.

Authors:  Aikaterini Hatzioannou; Saba Nayar; Anastasios Gaitanis; Francesca Barone; Constantinos Anagnostopoulos; Panayotis Verginis
Journal:  Oncoimmunology       Date:  2016-07-29       Impact factor: 8.110

8.  Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney.

Authors:  Yuki Sato; Akiko Mii; Yoko Hamazaki; Harumi Fujita; Hirosuke Nakata; Kyoko Masuda; Shingo Nishiyama; Shinsuke Shibuya; Hironori Haga; Osamu Ogawa; Akira Shimizu; Shuh Narumiya; Tsuneyasu Kaisho; Makoto Arita; Masashi Yanagisawa; Masayuki Miyasaka; Kumar Sharma; Nagahiro Minato; Hiroshi Kawamoto; Motoko Yanagita
Journal:  JCI Insight       Date:  2016-07-21

9.  Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma.

Authors:  Anthony B Rodriguez; J David Peske; Victor H Engelhard
Journal:  Methods Mol Biol       Date:  2018

10.  High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren's syndrome.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Santosh Kumar Mandal; Mahasampath Gowri; Debashish Danda
Journal:  Clin Rheumatol       Date:  2016-09-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.